Safety and immunogenicity of an HIV-1 tat toxoid vaccine in HIV-1 infected volunteers on highly active anti retroviral therapy (HAART)

被引:0
|
作者
Frachette, MJ [1 ]
机构
[1] Aventis Pasteur, F-69280 Marcy Letoile, France
来源
RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES | 2003年
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:179 / 181
页数:3
相关论文
共 50 条
  • [41] ANTI-CD4 ANTIIDIOTYPE ANTIBODIES IN VOLUNTEERS IMMUNIZED WITH RGP160 OF HIV-1 OR INFECTED WITH HIV-1
    KEAY, S
    TACKET, CO
    MURPHY, JR
    HANDWERGER, BS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) : 1091 - 1098
  • [42] Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
    Graham, Barney S.
    Koup, Richard A.
    Roederer, Mario
    Bailer, Robert T.
    Enama, Mary E.
    Moodie, Zoe
    Martin, Julie E.
    McCluskey, Margaret M.
    Chakrabarti, Bimal K.
    Lamoreaux, Laurie
    Andrews, Charla A.
    Gomez, Phillip L.
    Mascola, John R.
    Nabel, Gary J.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (12): : 1650 - 1660
  • [43] Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy
    Daniel Sánchez-Taltavull
    Arturo Vieiro
    Tomás Alarcón
    Journal of Mathematical Biology, 2016, 73 : 919 - 946
  • [44] Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy
    Sanchez-Taltavull, Daniel
    Vieiro, Arturo
    Alarcon, Tomas
    JOURNAL OF MATHEMATICAL BIOLOGY, 2016, 73 (04) : 919 - 946
  • [45] Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy
    Benlahrech, A.
    Yasmin, A.
    Westrop, S. J.
    Coleman, A.
    Herasimtschuk, A.
    Page, E.
    Kelleher, P.
    Gotch, F.
    Imami, N.
    Patterson, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 170 (02): : 212 - 221
  • [46] Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages
    Cribbs, Sushma K.
    Lennox, Jeffrey
    Caliendo, Angela M.
    Brown, Lou Ann
    Guidot, David M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 64 - 70
  • [47] CTL RESPONSES IN HIV-1 UNINFECTED VOLUNTEERS PARTICIPATING IN PHASE-1 HIV-1 VACCINE TRIALS
    MCELRATH, MJ
    COREY, L
    RABIN, M
    HOFFMAN, M
    KLUCKING, S
    GREENBERG, PD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 82 - 82
  • [48] Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission
    Bardeskar, Nikhil S.
    Ahir-Bist, Swati P.
    Mehta, Preeti R.
    Samant-Mavani, Padmaja
    Nanavati, Ruchi
    Mania-Pramanik, Jayanti
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (05) : 1229 - 1235
  • [49] Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission
    Nikhil S. Bardeskar
    Swati P. Ahir-Bist
    Preeti R. Mehta
    Padmaja Samant-Mavani
    Ruchi Nanavati
    Jayanti Mania-Pramanik
    Archives of Gynecology and Obstetrics, 2020, 302 : 1229 - 1235
  • [50] In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
    Vasan, Sandhya
    Hurley, Arlene
    Schlesinger, Sarah J.
    Hannaman, Drew
    Gardiner, David F.
    Dugin, Daniel P.
    Boente-Carrera, Mar
    Vittorino, Roselle
    Caskey, Marina
    Andersen, Johanne
    Huang, Yaoxing
    Cox, Josephine H.
    Tarragona-Fiol, Tony
    Gill, Dilbinder K.
    Cheeseman, Hannah
    Clark, Lorna
    Dally, Len
    Smith, Carol
    Schmidt, Claudia
    Park, Harriet H.
    Kopycinski, Jakub T.
    Gilmour, Jill
    Fast, Patricia
    Bernard, Robert
    Ho, David D.
    PLOS ONE, 2011, 6 (05):